Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). - Scullion, Kathleen M; MacIntyre, Iain M; Sloan-Dennison, Sian; Clark, Benjamin; Fineran, Paul; Mair, Joanne; Creasey, David; Rathmell, Cicely; Faulds, Karen; Graham, Duncan; Webb, David J; Dear, James W (Toxicological Sciences, 2024)